TABLE 2

Clinical characteristics according to the presence of regression of microalbuminuria at the evaluation period

Regression (n = 85)No regression (n = 131)P
Sex (men:women)52:3389:420.31
Age (years)62 ± 861 ± 90.49
Duration of diabetes (years)15 ± 813 ± 80.08
A1C (%)7.5 ± 1.07.5 ± 1.00.96
SBP (mmHg)138 ± 16136 ± 170.50
Diastolic blood pressure (mmHg)78 ± 977 ± 100.48
Total cholesterol (mg/dl)210 ± 32206 ± 290.33
Triglycerides (mg/dl)119 ± 52129 ± 710.28
HDL cholesterol (mg/dl)55 ± 1353 ± 130.21
BMI (kg/cm2)23.8 ± 3.724.2 ± 2.90.32
Serum creatinine (mg/dl)0.70 ± 0.170.73 ± 0.180.25
AER (μg/min)68 ± 4862 ± 480.41
Estimated sodium intake (g/day)14.0 ± 5.614.8 ± 5.00.30
Estimated protein intake (g · kg−1 · day−1)1.2 ± 0.31.3 ± 0.40.51
Retinopathy (%)85830.68
Use of ACE inhibitor or ARB (%)28240.51
Incidence cohort (%)20150.35
  • Data are means ± SD unless otherwise indicated.